Patient Privacy/Confidentiality & Safeguarding Regulated/Protected Information
IMPORTANT BROWSER INFORMATION
This site will not work on Internet Explorer 8. Please use:
The first half of 2020 saw a reduction in the number of reported cyberattack incidents, though active threats continued to plague the healthcare sector, from ransomware to insiders. The volume and intensity of cyberattacks on hospitals and health systems increased during the second half of 2020, and experts believe there is more to come. The Patient Privacy and Confidentiality & Safeguarding Regulated and Protected Information module covers topics focused on information security, specifically HIPAA, FERPA and information security. The information learned in this course will help to keep the information of patients, students, and employees safe and reduce the likelihood of a cyberattack.
THIS MODULE IS ONLY AVAILABLE TO JEFFERSON EMPLOYEES AND MAY BE ACCESSED VIA MYJEFFHUB-LEARNING.
To successfully complete this activity, the required evaluation must be completed immediately following the viewing of the module in its entirety. Thereafter, the evaluation will no longer be available and credits will not be issued.
This course is designed for physicians, physician assistants, pharmacists, and nurses.
Following this educational activity, learners will be able to:
- Recognize when there’s been a violation of information sharing (i.e. FERPA, HIPPA, etc.)
- Explain when it is acceptable and not acceptable to share sensitive information.
This educational activity received no commercial or in-kind support.
This educational activity is only available to Jefferson employees and may only be accessed through myJeffHub.
Conflict of interest
Thomas Jefferson University endorses the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.
All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity.
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).
Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.
Exception: According to the Standards, it is not required to identify, mitigate, or disclose relevant financial relationships for any of the following activities:
- Accredited education that is non-clinical, such as leadership or communication skills training.
- Accredited education where the learner group is in control of content, such as a spontaneous case conversation among peers.
- Accredited self-directed education where the learner controls their educational goals and reports on changes that resulted, such as learning from teaching, remediation, or a personal development plan.
Sandra Brooks, MD, MBA
Gerald Cleary, DO, MHCM, FAAP
Rodney Bell, MD
Michelle DeCastro, NP
Alice Isidro, NP
Shawn Mangan, NP
Brian Swift, Pharm.D., MBA
Naya Hargreave, PA
Kristan Davis, M.Ed.
Lisa Hadden, M.Ed.
Robert Taylor, JD
Henry Humphries, PhD
This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: This educational activity is designated for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards .25 nursing contact hours.
Pharmacists: This knowledge-based continuing education activity is designated for .25 contact hours of continuing education credit. JA4008236-0000-21-013-H03-P
Credits will be uploaded to CPE Monitor within 60 days following the completion of this activity.
This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.
Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other Healthcare Professionals: This educational activity is designated for .25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material qualifies for .25 PA Patient and Risk Management credit.
This enduring material expires December 31, 2023.
- 0.25 ACPE
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Attendance
- 0.25 CNE
- 0.25 PA
- 0.25 Patient Safety